Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

31.7K
Overview
31.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The co-creation of Foot Selfie, a patient-centered mobile intervention to prevent diabetic foot ulcers.

BMC health services research·2026
Same author

Climate change induced complex shifts in snake distributions expose people to snakebite and threaten biodiversity.

PLoS neglected tropical diseases·2026
Same author

Type 1 diabetes intervention clusters in resource-limited settings: a systematic review and economic evaluation.

The lancet. Diabetes & endocrinology·2026
Same author

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial.

European stroke journal·2026
Same author

Analogue insulin, GLP-1, and the WHO Model Essential Medicines List - Authors reply.

The lancet. Diabetes & endocrinology·2026
Same author

The prevalence, prevention, and treatment of cardiovascular diseases in Twelve African Countries (2014-2019): An analysis of the World Health Organisation STEPwise approach to chronic disease risk factor surveillance.

PloS one·2026

Related Experiment Video

Updated: Oct 13, 2025

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

3.4K

Access to antivenoms in the developing world: A multidisciplinary analysis.

Julien Potet1, David Beran2,3, Nicolas Ray4,5

  • 1Médecins Sans Frontières Access Campaign, Geneva, Switzerland.

Toxicon: X
|November 17, 2021
PubMed
Summary

Access to safe antivenom is limited by manufacturing, regulation, cost, and supply chain issues, particularly in resource-limited regions. Overcoming these barriers requires multifaceted interventions to reduce the global burden of snakebite envenoming.

Keywords:
AffordabilityAntivenomsHealth services accessibilityNeglected tropical diseasesRegulatory capacitySnakebite envenoming

More Related Videos

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
12:16

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli

Published on: July 30, 2014

24.4K
Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

34.0K

Related Experiment Videos

Last Updated: Oct 13, 2025

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

3.4K
High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
12:16

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli

Published on: July 30, 2014

24.4K
Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

34.0K

Area of Science:

  • * Global Health
  • * Pharmacovigilance
  • * Tropical Medicine

Background:

  • * Snakebite envenoming is a significant global health issue, disproportionately affecting tropical and subtropical regions.
  • * Access to safe, effective, and quality-assured antivenom is critical for managing snakebite envenoming but faces numerous challenges.
  • * Current efforts to reduce the burden of snakebite envenoming are hampered by multifaceted access barriers to antivenom products.

Purpose of the Study:

  • * To review the antivenom ecosystem and identify barriers to antivenom access at global, national, and local levels.
  • * To propose solutions for overcoming challenges in antivenom procurement, regulation, financing, and distribution.
  • * To inform strategies for improving antivenom availability and accessibility in resource-limited settings.

Main Methods:

  • * A comprehensive review of the antivenom supply chain and access landscape.
  • * Analysis of barriers at global (manufacturing), national (regulation, funding), and local (supply, cost, misconceptions) levels.
  • * Identification of actionable solutions aligned with the WHO Strategy for Prevention and Control of Snakebite Envenoming.

Main Results:

  • * Global manufacturing output is insufficient to meet clinical needs, especially in regions with limited producers.
  • * National-level issues include variable funding, inadequate regulation, and failure to register products locally.
  • * Patient-borne costs, unreliable peripheral supply chains, and misconceptions about treatment further impede access and appropriate use.

Conclusions:

  • * Multifaceted interventions are essential to improve antivenom access in resource-limited settings.
  • * Strengthening manufacturing, regulation, financing, and supply chains is crucial.
  • * Addressing patient-level barriers and misconceptions is vital to reduce the global burden of snakebite envenoming.